Neurava Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-16.
Neurava Inc. filed a Form D notice of an exempt securities offering with the SEC on October 16, 2025. The filing reports $1.60M sold. Its industry group is Other Technology. It names Jay Shah (Executive Officer, Director, Promoter), Vivek Ganesh (Executive Officer, Director, Promoter), Mona Chadha (Director) (SEC Form D, October 16, 2025).
Is this your company?
Sell to companies like Neurava Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-16 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Neurava Inc.
Free to see. No signup.
More on the people and the money behind Neurava Inc., from the filings we hold.
Other Technology raises by companies based in Maryland, filed within 90 days of this one, largest first.
Get an email when Neurava Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Neurava Inc. raises, hires or launches. No email unless you switch it on.
Watch Neurava Inc. →Get the full cited report on Neurava Inc.
What the filing shows about Neurava Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Neurava Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Neurava Inc.'s address as 101 W Dickman Street, Suite 807, Baltimore, MD 21230.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Neurava Inc. is a registered filer with the SEC (CIK 1882749) and has filed since 2023-01-06. 3 filings are on record, the latest on 2025-10-16.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Neurava Inc.'s Form D of 2025-10-16 names Jay Shah, Vivek Ganesh, Mona Chadha and 2 more as its officers, directors or promoters.
Its new offerings report $2.84M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Proceeds will be used for general corporate purposes. The above amount excludes salary and bonus compensation which may be made to officers, directors, employees, and consultants of the Issuer.
Checked away from the filing. What is below does not come from the record on sec.gov.
Giving Back Control To Patients
The title and description the site itself served, answering 200, after redirecting from https://neurava.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Jay Shah is named as Executive Officer and Director and Promoter on the Form D that Neurava Inc. filed with the SEC on 16 October 2025, one of 5 people that filing names.
Vivek Ganesh is named as Executive Officer and Director and Promoter on the Form D that Neurava Inc. filed with the SEC on 16 October 2025, one of 5 people that filing names.
Mona Chadha is named as Director on the Form D that Neurava Inc. filed with the SEC on 16 October 2025, one of 5 people that filing names.
John Kay is named as Director on the Form D that Neurava Inc. filed with the SEC on 16 October 2025, one of 5 people that filing names.
Daniel Moore is named as Director on the Form D that Neurava Inc. filed with the SEC on 16 October 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-10-16 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Neurava Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Neurava Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neurava Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Neurava Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Neurava Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (neurava.com).
Each opens in a new tab, filled in for Neurava Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Baltimore
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/neurava-inc-form-d-25000001